ERRATA

Author’s Clarification:

MEDICC Review’s July 2005 issue (Epidemics: The Cuban Approach, Vol. VII, No. 7, July 2005), carried Spotlight: Cuba’s Epidemic-Fighting Model by Francisco Rojas Ochoa, MD, PhD. On page 2, second paragraph, the author noted the “overall efficacy of the Cuban meningitis B vaccine, (VA-MENGOC-BC) was 69.3%,” citing “La enfermedad meningococcica en Cuba” (Valcarcel M, Rodriguez R, Ferry H. in Cronología de una epidemia. Havana, ECIMED, 1991, p. 307). This data refers to efficacy based only on preliminary data, since the same source (p. 397) reported 83% efficacy upon completion of trials.